| A comprehensive evaluation of the activity and selectivity profile of ligands for RGD-binding integrins TG Kapp, F Rechenmacher, S Neubauer, OV Maltsev, ... Scientific reports 7 (1), 1-13, 2017 | 536 | 2017 |
| Exploring the role of RGD-recognizing integrins in cancer M Nieberler, U Reuning, F Reichart, J Notni, HJ Wester, M Schwaiger, ... Cancers 9 (9), 116, 2017 | 388 | 2017 |
| A Triazacyclononane‐Based Bifunctional Phosphinate Ligand for the Preparation of Multimeric 68Ga Tracers for Positron Emission Tomography J Notni, P Hermann, J Havlíčková, J Kotek, V Kubíček, J Plutnar, ... Chemistry–A European Journal 16 (24), 7174-7185, 2010 | 191 | 2010 |
| TRAP, a Powerful and Versatile Framework for Gallium‐68 Radiopharmaceuticals J Notni, J Šimeček, P Hermann, HJ Wester Chemistry–A European Journal 52 (17), 14718-14722, 2011 | 179 | 2011 |
| Comparative gallium-68 labeling of TRAP-, NOTA-, and DOTA-peptides: practical consequences for the future of gallium-68-PET J Notni, K Pohle, HJ Wester EJNMMI research 2, 1-5, 2012 | 144 | 2012 |
| Complexation of metal ions with TRAP (1, 4, 7-triazacyclononane phosphinic acid) ligands and 1, 4, 7-triazacyclononane-1, 4, 7-triacetic acid: phosphinate-containing ligands as … J Simecek, M Schulz, J Notni, J Plutnar, V Kubicek, J Havlickova, ... Inorganic chemistry 51 (1), 577-590, 2012 | 133 | 2012 |
| 68Ga-NODAGA-RGD is a suitable substitute for 18F-Galacto-RGD and can be produced with high specific activity in a cGMP/GRP compliant automated process K Pohle, J Notni, J Bussemer, H Kessler, M Schwaiger, AJ Beer Nuclear medicine and biology 39 (6), 777-784, 2012 | 119 | 2012 |
| Imaging the cytokine receptor CXCR4 in atherosclerotic plaques with the radiotracer 68Ga-pentixafor for PET F Hyafil, J Pelisek, I Laitinen, M Schottelius, M Mohring, Y Döring, ... Journal of Nuclear Medicine 58 (3), 499-506, 2017 | 114 | 2017 |
| Be spoilt for choice with radiolabelled RGD peptides: preclinical evaluation of 68 Ga-TRAP (RGD) 3 J Notni, K Pohle, HJ Wester Nuclear medicine and biology 40 (1), 33-41, 2013 | 109 | 2013 |
| Synthesis and preclinical characterization of the PSMA-targeted hybrid tracer PSMA-I&F for nuclear and fluorescence imaging of prostate cancer M Schottelius, A Wurzer, K Wissmiller, R Beck, M Koch, D Gorpas, J Notni, ... Journal of Nuclear Medicine 60 (1), 71-78, 2019 | 90 | 2019 |
| Re‐thinking the role of radiometal isotopes: Towards a future concept for theranostic radiopharmaceuticals J Notni, HJ Wester Journal of Labelled Compounds and Radiopharmaceuticals 61 (3), 141-153, 2018 | 85 | 2018 |
| How is 68Ga Labeling of Macrocyclic Chelators Influenced by Metal Ion Contaminants in 68Ge/68Ga Generator Eluates? J Šimeček, P Hermann, HJ Wester, J Notni ChemMedChem 8 (1), 95-103, 2013 | 85 | 2013 |
| Comparison of cyclic RGD peptides for αvβ3 integrin detection in a rat model of myocardial infarction I Laitinen, J Notni, K Pohle, M Rudelius, E Farrell, SG Nekolla, ... EJNMMI research 3, 1-9, 2013 | 76 | 2013 |
| Phosphinic acid functionalized polyazacycloalkane chelators for radiodiagnostics and radiotherapeutics: unique characteristics and applications J Notni, J Šimeček, HJ Wester ChemMedChem 9 (6), 1107-1115, 2014 | 69 | 2014 |
| Benefits of NOPO As Chelator in Gallium-68 Peptides, Exemplified by Preclinical Characterization of 68Ga-NOPO–c(RGDfK) J Simecek, J Notni, TG Kapp, H Kessler, HJ Wester Molecular Pharmaceutics 11 (5), 1687-1695, 2014 | 66 | 2014 |
| Formation of a Unique Zinc Carbamate by CO2 Fixation: Implications for the Reactivity of Tetra-Azamacrocycle Ligated Zn(II) Complexes J Notni, S Schenk, H Görls, H Breitzke, E Anders Inorganic chemistry 47 (4), 1382-1390, 2008 | 65 | 2008 |
| A shortcut to high-affinity Ga-68 and Cu-64 radiopharmaceuticals: one-pot click chemistry trimerisation on the TRAP platform Z Baranyai, D Reich, A Vágner, M Weineisen, I Tóth, HJ Wester, J Notni Dalton Transactions 44 (24), 11137-11146, 2015 | 64 | 2015 |
| In vivo PET imaging of the cancer integrin αvβ6 using 68Ga-labeled cyclic RGD nonapeptides J Notni, D Reich, OV Maltsev, TG Kapp, K Steiger, F Hoffmann, I Esposito, ... Journal of Nuclear Medicine 58 (4), 671-677, 2017 | 63 | 2017 |
| Tailored gallium (III) chelator NOPO: synthesis, characterization, bioconjugation, and application in preclinical Ga-68-PET imaging J Simecek, O Zemek, P Hermann, J Notni, HJ Wester Molecular pharmaceutics 11 (11), 3893-3903, 2014 | 60 | 2014 |
| Tailored gallium (III) chelator NOPO: synthesis, characterization, bioconjugation, and application in preclinical Ga-68-PET imaging J Simecek, O Zemek, P Hermann, J Notni, HJ Wester Molecular pharmaceutics 11 (11), 3893-3903, 2014 | 60 | 2014 |
